41 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 41 of 41 clinical reviews.
A clinical guide to acute insomnia covering diagnosis, first-line cognitive behavioral therapy, FDA-approved medications, and related sleep disorders including obstructive sleep apnea, restless legs syndrome, and periodic limb movement disorder.
Zolpidem 10mg is the max dose for men; women start at 5mg per FDA rules. See onset, half-life, side effects, and when to stop after 2 to 4 weeks.
Nightly Ambien (zolpidem) use carries real risks of tolerance, dependence, and next-day impairment. Learn what the FDA, clinical trials, and sleep-medicine guidelines say about safe duration, safer alternatives, and how to taper off.
CBT-I outperforms sleep medication long-term, with 70-80% of patients reaching normal sleep. Learn diagnosis criteria and when to rule out sleep apnea first.
An evidence-based guide to delayed and advanced sleep-wake phase disorder, non-24, irregular rhythm, shift work disorder, and jet lag.
A comprehensive breakdown of sleep medication costs, from older generics like temazepam to newer dual orexin receptor antagonists like suvorexant and lemborexant, including insurance coverage tips and out-of-pocket strategies.
A guide to daridorexant (Quviviq) covering mechanism, dosing, clinical trial data, and head-to-head comparisons with zolpidem, eszopiclone, zaleplon, and melatonin for chronic insomnia.
Discontinuation insomnia is the rebound wakefulness that follows stopping sedative-hypnotic drugs. Learn which agents cause it, how long it lasts, and what evidence-based strategies minimize it.
A comparison of dual orexin receptor antagonists (suvorexant, lemborexant), Z-drugs (zolpidem, eszopiclone, zaleplon), trazodone, ramelteon, and melatonin for chronic insomnia. Covers efficacy data, abuse potential, next-day impairment, and who should get what.
Doxepin targets H1 receptors to help you stay asleep, while zolpidem acts faster on GABA to help you fall asleep. See which matches your insomnia type.
A guide to eszopiclone (Lunesta): FDA-approved doses, mechanism of action, side effects, drug interactions, and head-to-head comparisons with zolpidem (Ambien), zaleplon (Sonata), suvorexant (Belsomra), and melatonin.
A guide to gabapentin for sleep covering mechanism, dosing, evidence from named trials, side effects, and head-to-head comparisons with melatonin, zolpidem, eszopiclone, and zaleplon.
Effective doses run 0.5-3 mg nightly; 10 mg is the clinical upper limit with no added benefit. Learn overdose signs and safer alternatives.
A guide to insurance coverage for dual orexin receptor antagonists (DORAs) like suvorexant and lemborexant, including cost breakdowns, prior authorization requirements, and step-therapy protocols.
Ambien (zolpidem) carries real addiction and dependence risk. Learn what the FDA says, how nightly use changes your brain, and which evidence-backed alternatives, trazodone, melatonin, magnesium glycinate, may work instead.
Lemborexant (5-10mg) cut sleep-onset latency by 22 minutes vs placebo in SUNRISE-2, with no next-morning driving impairment and low dependence risk.
Studies show 320-500mg at bedtime modestly improves sleep quality in 4-8 weeks, cutting insomnia scores by about 3 points. Not a sedative.
A clinical comparison of melatonin and ramelteon for insomnia, including dosing, mechanism, safety, and how they stack up against Ambien, Lunesta, trazodone, mirtazapine, Belsomra, and CPAP therapy.
A guide to using mirtazapine for sleep: how it works, what doses are used off-label, trial data, and a head-to-head comparison with zolpidem, eszopiclone, zaleplon, and melatonin.
A guide to modafinil and armodafinil covering FDA-approved indications, dosing, pharmacokinetics, side effects, drug interactions, and how these wakefulness agents compare to zolpidem, eszopiclone, zaleplon, and melatonin.
Learn how narcolepsy type 1 and type 2 differ in symptoms, CSF hypocretin levels, diagnosis criteria, and FDA-approved treatments including sodium oxybate and pitolisant.
A guide to obstructive sleep apnea covering AHI thresholds, CPAP protocols, surgical options, and links to insomnia, restless legs syndrome, and periodic limb movement disorder.
PLMD treatment starts with dopamine agonists like pramipexole or ropinirole, plus iron repletion if ferritin is under 75 ng/mL. See diagnostic criteria.
Melatonin is OTC in the US but prescription-only in the EU, UK, Canada, and Australia. Effective dose is 0.5-3mg, far below typical 5-10mg supplements.
A clinical deep-dive into off-label quetiapine (Seroquel) for insomnia: how it works, what the evidence shows, safety risks at low doses, and how it compares to melatonin, zolpidem, eszopiclone, and zaleplon.
RBD causes people to act out dreams during REM sleep. Learn why it's often an early sign of neurodegenerative disease and how it's diagnosed and treated.
A guide to restless legs syndrome (RLS): diagnostic criteria, dopaminergic and non-dopaminergic treatments, links to periodic limb movement disorder, sleep apnea, and chronic insomnia, plus when to escalate care.
Shift work sleep disorder causes chronic insomnia and excessive sleepiness in night-shift and rotating-shift workers. Learn how clinicians diagnose it, which medications are approved, and what behavioral strategies reduce long-term risk.
Evidence-based strategies for shift workers, older adults, pregnant women, postmenopausal women, and travelers dealing with circadian misalignment, sleep loss, and jet lag.
A clinical guide to sleep changes in older adults, postmenopausal women, pregnant patients, shift workers, and frequent travelers, with evidence-based treatment options and a framework for identifying which mechanism is driving the disruption.
Postmenopausal women face unique sleep challenges driven by estrogen loss, hot flashes, and circadian changes. This evidence-based guide covers proven treatments, from menopausal hormone therapy to CBT-I, light therapy, and sleep hygiene tailored to older adults, shift workers, and travelers.
Evidence-based guidance on managing sleep disorders across life stages and situations, including pregnancy, postmenopausal insomnia, older adults, shift workers, and jet-lag recovery protocols.
A guide to sodium oxybate (Xyrem) for narcolepsy, covering FDA-approved dosing, trial data, side effects, REMS requirements, and comparisons with melatonin, zolpidem, eszopiclone, and zaleplon.
A guide to suvorexant (Belsomra) covering mechanism, FDA-approved dosing, head-to-head comparisons with zolpidem, eszopiclone, zaleplon, and melatonin, plus safety data from randomized controlled trials.
A clinical guide to how benzodiazepines, Z-drugs, and other sleep medications cause tolerance and physical dependence, with evidence-based tapering strategies and safer long-term alternatives.
A guide to jet lag covering causes, melatonin dosing, light therapy, medications, and special considerations for older adults, pregnant women, postmenopausal women, and shift workers.
Trazodone treats insomnia off-label at 25-150mg before bed, easing sedation without dependence risk; typical start dose is 25-50mg, effects begin in 30-60 minutes.
Mirtazapine (Remeron) is an antidepressant used off-label at 7.5-15 mg for sleep. It improves sleep continuity but can cause weight gain and grogginess.
Z-drugs like zolpidem, zaleplon, and eszopiclone can trigger complex sleep behaviors including sleepwalking, sleep-driving, and sleep-eating. Learn what the FDA says, how to recognize the risks, and when to stop.
A guide to zaleplon (Sonata): FDA-approved dosing, mechanism of action, side effects, drug interactions, and how it compares with zolpidem, eszopiclone, suvorexant, and melatonin.
Trazodone (25-100mg, off-label) isn't controlled like zaleplon and carries less dependence risk, but has a smaller insomnia trial base.